Conditions

No differences in the barriers to weight loss and weight loss success were observed between the intermittent (IER) and continuous (CER) dieters.

Despite being on first-line oral anti-diabetic drug therapy, the risk of developing CVD/CKD in patients with type 2 diabetes remains high.

The Look AHEAD trial had dramatic results for patients with T2D and their risk for cardiovascular disease (CVD). 

How does intensive medical therapy (IMT) compare with surgical treatment in improving patients' quality of life? 

Black patients may have lower odds of achieving target HbA1C levels on metformin and SGLT2 alone. 

A 16-week low-fat plant-based diet significantly improves diabetes parameters in adult patients with type 2 diabetes mellitus (T2DM). 

Is the current guidelines’ recommendation of moderate exercise for 150 minutes per week during pregnancy enough to reduce the risk of gestational diabetes? 

By Sheri Colberg, PhD
I recently was asked about the latest research on the reversal of type 2 diabetes—both bariatric and non-bariatric solutions—and it made me wonder about the mechanisms of this possibility and what role being active may play in it. Each new year always brings a whole host of resolutions that people make focused on losing weight, getting more fit, and becoming healthier. Especially with all the COVID-related pounds I have heard about people gaining, I expect these resolutions to be out in full force at the start of 2022. But how effective will they be long-term, and is the reversal of type 2 diabetes a realistic resolution to make?

Sodium-glucose cotransporter 2 (SGLT2) inhibitors were created to treat diabetes, but noted to ameliorate cardiovascular events. 

Health plans with high deductibles require thousands of dollars out-of-pocket and have a known association with delays in treatment; a repeated cross-sectional study found they are also associated with medication non-adherence.